NEUROD1 and obesity disorder: Twelve weeks postpartum, in these subjects with NEUROD1 variants and obesity, we performed an oral glucose tolerance test; both showed a significant reduction in insulin release at 1 and 2 hours when compared with T2D and control subjects (S1 Fig).